Arbutus Biopharma Corp (ABUS)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $73k
- Feb 4 · Routine
- Form 4 sales
- 19
- On record
- Form 144 notices
- 11
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineFeb 4, 2025 2025
Sold 22,183 shares at $3.28 ($73k)
Hastings David C, Chief Financial Officer
10b5-1 planSold 12.2% of holdings ($597k position)159,724 shares leftFollows a Form 144Filing
- 2 Form 144 noticeNoticeMar 7, 2025 +31 days
Filed to sell 167,162 shares ($550k)
Sofia Michael J., Member of immediate family of any of the foregoing
No 10b5-1 planFiling
- 3 Form 144 noticeNoticeMar 13, 2025 +6 days
Filed to sell 100,000 shares ($338k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 4 Form 144 noticeNoticeMar 19, 2025 +6 days
Filed to sell 150,000 shares ($480k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 5 Form 144 noticeNoticeMar 24, 2025 +5 days
Filed to sell 250,000 shares ($820k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 6 Form 144 noticeNoticeMar 31, 2025 +7 days
Filed to sell 250,000 shares ($875k)
Sofia Michael J., Officer
No 10b5-1 planFiling
- 7 Form 144 noticeNoticeApr 15, 2025 +15 days
Filed to sell 53,114 shares ($170k)
McElhaugh Michael J., Director
No 10b5-1 planFiling
- 8 Form 144 noticeNoticeApr 21, 2025 +6 days
Filed to sell 246,886 shares ($805k)
McElhaugh Michael J., Director
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales, notices and lockups (30)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Apr 21, 2025 | McElhaugh Michael J. | ABUS | Director | Form 144 notice | 246,886 | $805k | Notice | SEC | |
| Apr 15, 2025 | Apr 15, 2025 | McElhaugh Michael J. | ABUS | Director | Form 144 notice | 53,114 | $170k | Notice | SEC | |
| Mar 31, 2025 | Mar 31, 2025 | Sofia Michael J. | ABUS | Officer | Form 144 notice | 250,000 | $875k | Notice | SEC | |
| Mar 24, 2025 | Mar 24, 2025 | Sofia Michael J. | ABUS | Officer | Form 144 notice | 250,000 | $820k | Notice | SEC | |
| Mar 19, 2025 | Mar 19, 2025 | Sofia Michael J. | ABUS | Officer | Form 144 notice | 150,000 | $480k | Notice | SEC | |
| Mar 13, 2025 | Mar 13, 2025 | Sofia Michael J. | ABUS | Officer | Form 144 notice | 100,000 | $338k | Notice | SEC | |
| Mar 7, 2025 | Mar 7, 2025 | Sofia Michael J. | ABUS | Member of immediate family of any of the foregoing | Form 144 notice | 167,162 | $550k | Notice | SEC | |
| Feb 4, 2025 | Feb 5, 2025 | Hastings David C | ABUS | Chief Financial Officer | Form 4 sale | 22,183 | $73k | 12.2% | Routine | SEC |
| Feb 4, 2025 | Feb 5, 2025 | Sims Karen | ABUS | Chief Medical Officer | Form 4 sale | 19,348 | $63k | 15.4% | Routine | SEC |
| Feb 4, 2025 | Feb 5, 2025 | McElhaugh Michael J. | ABUS | Interim President & CEO | Form 4 sale | 23,790 | $78k | 1.6% | Routine | SEC |
| Feb 4, 2025 | Feb 5, 2025 | Naftzger J. Christopher | ABUS | General Counsel and CCO | Form 4 sale | 11,333 | $37k | 11.6% | Routine | SEC |
| Feb 4, 2025 | Feb 4, 2025 | Hastings David C | ABUS | Officer | Form 144 notice | 22,183 | $73k | Notice | SEC | |
| Feb 4, 2025 | Feb 4, 2025 | Sims Karen | ABUS | Officer | Form 144 notice | 19,348 | $64k | Notice | SEC | |
| Feb 4, 2025 | Feb 4, 2025 | McElhaugh Michael J. | ABUS | Director and Officer | Form 144 notice | 23,790 | $78k | Notice | SEC | |
| Feb 4, 2025 | Feb 4, 2025 | Naftzger J. Christopher | ABUS | Officer | Form 144 notice | 11,333 | $37k | Notice | SEC | |
| Aug 14, 2024 | Aug 16, 2024 | Manchester Keith S | ABUS | Director | Form 4 sale | 8,846 | $33k | 16.1% | No plan | SEC |
| Feb 2, 2024 | Feb 5, 2024 | Sims Karen | ABUS | Chief Medical Officer | Form 4 sale | 4,358 | $10k | 3.4% | Routine | SEC |
| Feb 2, 2024 | Feb 5, 2024 | Hastings David C | ABUS | Chief Financial Officer | Form 4 sale | 9,593 | $22k | 5.0% | Routine | SEC |
| Feb 2, 2024 | Feb 5, 2024 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 9,982 | $23k | 0.7% | Routine | SEC |
| Feb 2, 2024 | Feb 5, 2024 | McElhaugh Michael J. | ABUS | Interim President & CEO | Form 4 sale | 10,164 | $23k | 0.7% | Routine | SEC |
| Dec 1, 2021 | Dec 3, 2021 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 200,000 | $1M | 13.3% | Plan not stated | SEC |
| Feb 9, 2021 | Feb 10, 2021 | McElhaugh Michael J. | ABUS | Chief Business Officer | Form 4 sale | 20,000 | $100k | 1.5% | Plan not stated | SEC |
| Dec 14, 2020 | Dec 16, 2020 | McElhaugh Michael J. | ABUS | Chief Business Officer | Form 4 sale | 40,000 | $200k | 2.9% | Plan not stated | SEC |
| Jul 23, 2020 | Jul 27, 2020 | McElhaugh Michael J. | ABUS | Chief Business Officer | Form 4 sale | 20,000 | $100k | 1.4% | Plan not stated | SEC |
| Aug 13, 2018 | Aug 14, 2018 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 4,250 | $40k | 0.3% | Plan not stated | SEC |
| Jul 11, 2018 | Jul 13, 2018 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 10,000 | $100k | 0.7% | Plan not stated | SEC |
| Jul 9, 2018 | Jul 10, 2018 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 20,000 | $174k | 1.3% | Plan not stated | SEC |
| Jul 5, 2018 | Jul 6, 2018 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 20,000 | $164k | 1.3% | Plan not stated | SEC |
| Oct 3, 2017 | Oct 5, 2017 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 10,000 | $80k | 0.6% | Plan not stated | SEC |
| Aug 15, 2017 | Aug 17, 2017 | Sofia Michael J. | ABUS | Chief Scientific Officer | Form 4 sale | 30,000 | $111k | 14.9% | Plan not stated | SEC |